These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2380576)

  • 1. Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma.
    Chi HI; Ishibashi Y; Shima A; Mihara I; Otsuka F
    J Invest Dermatol; 1990 Aug; 95(2):154-7. PubMed ID: 2380576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful differentiation of Spitz naevus from malignant melanoma by microfluorometric analysis of cellular DNA content.
    Otsuka F; Chi HI; Umebayashi Y
    Clin Exp Dermatol; 1993 Sep; 18(5):421-4. PubMed ID: 8252762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
    Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry.
    Winokur TS; Palazzo JP; Johnson WC; Duray PH
    J Cutan Pathol; 1990 Dec; 17(6):342-7. PubMed ID: 2074280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
    Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
    Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of Spitz nevus and nodular malignant melanoma using image analysis cytometry.
    LeBoit PE; Van Fletcher H
    J Invest Dermatol; 1987 Jun; 88(6):753-7. PubMed ID: 3295064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spitz nevi.
    Casso EM; Grin-Jorgensen CM; Grant-Kels JM
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):901-13. PubMed ID: 1479095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid.
    Vogt T; Stolz W; Glässl A; Abmayr W; Hohenleutner U; Schmoeckel C; Schiffner R; Landthaler M
    Am J Dermatopathol; 1996 Apr; 18(2):142-50. PubMed ID: 8739988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of DNA ploidy measurements in Spitz nevi.
    Skowronek J; Warchoł JB; Karaś Z; Krenz RM
    Pol J Pathol; 2000; 51(1):45-50. PubMed ID: 10833903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-cytophotometry of benign compound and intradermal naevi, Spitz epithelioid naevi and malignant melanomas.
    Lindholm C; Bjelkenkrantz K; Hofer PA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(4):257-8. PubMed ID: 2890239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
    Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
    J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
    McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
    J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silhouette symmetry: an unsupportable histologic criterion for distinguishing Spitz nevi and compound nevi from malignant melanoma.
    Okun MR
    Arch Pathol Lab Med; 1997 Jan; 121(1):48-53. PubMed ID: 9111092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmented Spitz nevi: improvement of the diagnostic accuracy by epiluminescence microscopy.
    Steiner A; Pehamberger H; Binder M; Wolff K
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):697-701. PubMed ID: 1430390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient age in Spitz nevus and malignant melanoma: implication of Bayes rule for differential diagnosis.
    Vollmer RT
    Am J Clin Pathol; 2004 Jun; 121(6):872-7. PubMed ID: 15198360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Expression Analysis Differentiates Melanomas from Spitz Nevi.
    Jansen B; Hansen D; Moy R; Hanhan M; Yao Z
    J Drugs Dermatol; 2018 May; 17(5):574-576. PubMed ID: 29742191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.